Back to Search Start Over

Aivita Biomedical gets US FDA nod to begin phase II trial of ROOT OF CANCER technology in patients with glioblastoma multiforme

Source :
PharmaBiz. June 22, 2018
Publication Year :
2018

Abstract

Aivita Biomedical, a biotech company specializing in innovative stem cell applications, announced the US Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for a phase [...]

Subjects

Subjects :
United States. Food and Drug Administration
Clinical trials
Cancer treatment
Cancer -- Care and treatment
Medical research
Stem cells
Cancer patients -- Care and treatment
Ovarian cancer -- Care and treatment
Glioblastomas -- Care and treatment
Pharmaceuticals and cosmetics industries

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.543884154

Tools

Authors Abstract Subjects Details